These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 38199914)

  • 21. Clinical Value of FDG-PET/CT in Multiple Myeloma: An Update.
    Bezzi D; Ambrosini V; Nanni C
    Semin Nucl Med; 2023 May; 53(3):352-370. PubMed ID: 36446644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Whole-Body [
    Berzaczy D; Fueger B; Hoeller C; Haug AR; Staudenherz A; Berzaczy G; Weber M; Mayerhoefer ME
    Mol Imaging Biol; 2020 Jun; 22(3):739-744. PubMed ID: 31363965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional Imaging for Therapeutic Assessment and Minimal Residual Disease Detection in Multiple Myeloma.
    Jamet B; Zamagni E; Nanni C; Bailly C; Carlier T; Touzeau C; Michaud AV; Moreau P; Bodet-Milin C; Kraeber-Bodere F
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evolving role of FDG PET/CT in multiple myeloma imaging and management.
    Agarwal A; Chirindel A; Shah BA; Subramaniam RM
    AJR Am J Roentgenol; 2013 Apr; 200(4):884-90. PubMed ID: 23521465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 11C-acetate positron emission tomography is more precise than 18F-fluorodeoxyglucose positron emission tomography in evaluating tumor burden and predicting disease risk of multiple myeloma.
    Chen M; Zhu W; Du J; Yang C; Han B; Zhou D; Huo L; Zhuang J
    Sci Rep; 2021 Nov; 11(1):22188. PubMed ID: 34773054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. F-18 FDG uptake of bone marrow on PET/CT scan: it's correlation with CD38/CD138 expressing myeloma cells in bone marrow of patients with multiple myeloma.
    Ak I; Gulbas Z
    Ann Hematol; 2011 Jan; 90(1):81-7. PubMed ID: 20690019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multi-parametric whole-body MRI evaluation discerns vital from non-vital multiple myeloma lesions as validated by
    Heidemeier A; Schloetelburg W; Thurner A; Metz C; Heidemeier H; Rasche L; Martin Kortuem K; Boeckle D; Weiland E; Benkert T; Nickel D; Werner R; Buck AK; Bley TA
    Eur J Radiol; 2022 Oct; 155():110493. PubMed ID: 36027759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utility of Molecular Imaging with 2-Deoxy-2-[Fluorine-18] Fluoro-DGlucose Positron Emission Tomography (18F-FDG PET) for Small Cell Lung Cancer (SCLC): A Radiation Oncology Perspective.
    Sager O; Dincoglan F; Demiral S; Uysal B; Gamsiz H; Elcim Y; Gundem E; Dirican B; Beyzadeoglu M
    Curr Radiopharm; 2019; 12(1):4-10. PubMed ID: 30465520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 18F-FDG PET/CT in myeloma with presumed solitary plasmocytoma of bone.
    Nanni C; Rubello D; Zamagni E; Castellucci P; Ambrosini V; Montini G; Cavo M; Lodi F; Pettinato C; Grassetto G; Franchi R; Gross MD; Fanti S
    In Vivo; 2008; 22(4):513-7. PubMed ID: 18712181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [18F-fluorodesoxyglucose positron emission tomography/computed tomography in extramedullary multiple myeloma].
    Lissarrague E; Fregeiro MS; Binstok Y; Barla C; Cavani M; Frachia F; Ranero S; Servente L; Riva E
    Rev Med Chil; 2022 Feb; 150(2):199-205. PubMed ID: 36156646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of 18F-Fluorodeoxyglucose Positron Emission Tomography or Positron Emission Tomography/Computed Tomography for the Detection of Recurrent Disease after Treatment of Malignant Melanoma.
    Lee JW; Nam SB; Kim SJ
    Oncology; 2019; 97(5):286-293. PubMed ID: 31437839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PET with Fluorodeoxyglucose F 18/Computed Tomography as a Staging Tool in Multiple Myeloma.
    Seval GC; Ozkan E; Beksac M
    PET Clin; 2019 Jul; 14(3):369-381. PubMed ID: 31084776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of multimodality integrated positron emission tomography-computed tomography on improving the staging and management of head and neck malignancy: a cross- sectional study.
    Subha ST; Nordin AJ
    Sao Paulo Med J; 2022; 140(3):454-462. PubMed ID: 35507996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
    Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
    Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of initial FDG-PET/CT and serum-free light chain on transformation of conventionally defined solitary plasmacytoma to multiple myeloma.
    Fouquet G; Guidez S; Herbaux C; Van de Wyngaert Z; Bonnet S; Beauvais D; Demarquette H; Adib S; Hivert B; Wemeau M; Berthon C; Terriou L; Coiteux V; Macro M; Decaux O; Facon T; Huglo D; Leleu X
    Clin Cancer Res; 2014 Jun; 20(12):3254-60. PubMed ID: 24714772
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Morales-Lozano MI; Rodriguez-Otero P; Sancho L; Nuñez-Cordoba JM; Prieto E; Marcos-Jubilar M; Rosales JJ; Alfonso A; Guillen EF; San-Miguel J; Garcia-Velloso MJ
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic performance of
    Basha MAA; Hamed MAG; Refaat R; AlAzzazy MZ; Bessar MA; Mohamed EM; Ahmed AF; Tantawy HF; Altaher KM; Obaya AA; Afifi AHM
    Jpn J Radiol; 2018 Jun; 36(6):382-393. PubMed ID: 29671193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imaging minimal residual disease evaluation in multiple myeloma using [
    Barilà G; Crimì F; Arangio Febbo M; Pavan L; Vedovato S; Cabrelle G; Zanon C; Campi C; Cecchin D; Zucchetta P; Lacognata C; Semenzato G; Zambello R
    Leuk Lymphoma; 2023 Feb; 64(2):503-506. PubMed ID: 36382776
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparative Performance of Whole-Body MRI and FDG PET/CT in Evaluation of Multiple Myeloma Treatment Response: Systematic Review and Meta-Analysis.
    Rama S; Suh CH; Kim KW; Durieux JC; Ramaiya NH; Tirumani SH
    AJR Am J Roentgenol; 2022 Apr; 218(4):602-613. PubMed ID: 34704461
    [No Abstract]   [Full Text] [Related]  

  • 40. [The value of 18F-fluoro-2-deoxy-D-glucose positron emission tomography (18F-FDG PET) in diagnosis of neoplastic diseases].
    Ruiz Hernández G; Romero de Avila Y Avalos C; Carreras Delgado JL
    Med Clin (Barc); 2005 Feb; 124(6):229-36. PubMed ID: 15737307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.